Asset Dedication LLC’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$613 Hold
65
﹤0.01% 1142
2026
Q1
$530 Hold
65
﹤0.01% 1050
2025
Q4
$437 Hold
65
﹤0.01% 1090
2025
Q3
$564 Hold
65
﹤0.01% 1095
2025
Q2
$410 Hold
65
﹤0.01% 1131
2025
Q1
$417 Hold
65
﹤0.01% 1069
2024
Q4
$523 Hold
65
﹤0.01% 1047
2024
Q3
$821 Hold
65
﹤0.01% 1070
2024
Q2
$823 Hold
65
﹤0.01% 1114
2024
Q1
$0 Hold
65
﹤0.01% 1026
2023
Q4
$0 Hold
65
﹤0.01% 1033
2023
Q3
$0 Hold
65
﹤0.01% 1034
2023
Q2
$0 Hold
65
﹤0.01% 1015
2023
Q1
$0 Hold
65
﹤0.01% 1033
2022
Q4
$1K Hold
65
﹤0.01% 947
2022
Q3
$1K Buy
+65
New +$2.82K ﹤0.01% 898

Other funds holding NVAX

Asset Dedication LLC's NVAX Position: Q2 2026 in Review

Asset Dedication LLC held its Novavax (NVAX) position steady in Q2 2026 at 65 shares worth $613. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Asset Dedication LLC first reported a position in NVAX in Q3 2022 and has held it in 16 quarters since. The position peaked at $1K in Q4 2022. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Asset Dedication LLC held 65 shares of Novavax worth $613 as of Q2 2026.
  • Asset Dedication LLC left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #1142 holding.
  • Asset Dedication LLC first reported a position in Novavax in Q3 2022 and has held it in 16 quarters since.
  • Asset Dedication LLC's Novavax position peaked at $1K in Q4 2022.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.